Protozoal infections remain a major public health challenge across Nigeria, particularly in rural and tropical communities. Environmental factors such as stagnant water, poor sanitation, and high humidity favor the life cycle of vectors and parasites. Malaria, caused by *Plasmodium* species, is responsible for significant morbidity and mortality, especially among pregnant women and children under five. Amoebiasis and giardiasis are also widespread, driven by contaminated drinking water and poor food hygiene. Nurses must understand these local epidemiological patterns to recognize clinical presentations early and provide targeted care within primary health clinics and tertiary facilities.
Antiprotozoal medications are grouped based on the specific parasites they target and their biochemical pathways.
Infections caused by intestinal protozoa require targeted pharmaceutical intervention to clear the organisms from the gastrointestinal tract. Metronidazole remains the frontline agent for symptomatic amoebiasis and giardiasis. Following tissue-invasive amoebiasis treatment, luminal agents such as diloxanide furoate are often necessary to eradicate cysts remaining in the bowel lumen and prevent relapse. Nurses must monitor stool consistency and frequency to evaluate the effectiveness of these therapies during hospital admissions or outpatient follow-up.
Systemic protozoal infections like malaria require aggressive pharmacological management to prevent organ failure and death. Artemether-lumefantrine is the standard first-line treatment for uncomplicated falciparum malaria in Nigeria. For severe or complicated malaria, parenteral artesunate is administered intravenously or intramuscularly until the patient can tolerate oral medications. Quinine is maintained as a reliable alternative when resistance or supply issues arise. Nurses must calculate dosages meticulously based on patient weight and monitor parasite clearance rates.
Optimizing the therapeutic efficacy of antiprotozoal drugs depends on proper administration and an understanding of how the body processes them. Oral artemether-lumefantrine absorption significantly improves when taken with fatty foods or milk, a detail nurses must emphasize during medication dispensing. Metronidazole tablets should be swallowed whole with adequate water, and patients must strictly avoid alcohol consumption during treatment and for at least forty-eight hours afterward to prevent severe disulfiram-like reactions.
Like most antimicrobial therapies, antiprotozoal agents carry a profile of side effects and clinical contraindications. Common adverse reactions include metallic taste, nausea, and epigastric discomfort, particularly with nitroimidazoles. Chloroquine frequently causes mild pruritus, which can be distressing to patients but is usually not a true allergic reaction. High doses or rapid intravenous administration of quinine can lead to cinchonism, characterized by tinnitus, headache, and blurred vision. Nurses must screen patients for known hypersensitivities and underlying cardiac or hepatic conditions before drug administration.
Comprehensive nursing care involves systematic baseline assessments and continuous monitoring throughout the treatment course. Nurses should evaluate vital signs, neurological status, and hydration levels, especially in patients presenting with severe systemic infections. Monitoring fluid intake and output prevents renal complications associated with drug toxicity or severe dehydration from diarrhea and vomiting. Laboratory follow-up, including packed cell volume and blood film microscopy, helps confirm parasite clearance and therapeutic success.
Long-term control of protozoal infections depends heavily on community education and environmental hygiene practices. Nurses must educate patients on utilizing insecticide-treated bed nets, clearing surrounding brush, and eliminating stagnant water breeding sites for mosquitoes. For intestinal parasites, teaching proper handwashing techniques, drinking safe potable water, and ensuring thorough food preparation are vital. Empowering individuals with preventive knowledge breaks the transmission cycle and reduces recurrent clinic visits.